Alejandro Schcolnik‐Cabrera
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Parasitology top 10%
- Parasites and Host Interactions
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Epigenetics and DNA Methylation 3
- Immunology 10
- Immune Cell Function and Interaction 3
- Immune cells in cancer 3
- Co-authors
- Alfonso Dueñas‐González (11 shared papers)Mandy Juárez (7 shared papers)Guadalupe Domínguez-Gómez (9 shared papers)Alma Chávez‐Blanco (9 shared papers)Fela Mendlovic (3 shared papers)Bernardo Oldak (2 shared papers)Ana Flisser (2 shared papers)Mayra Cruz‐Rivera (2 shared papers)
- Journals
- Current Medicinal Chemistry (2 papers)Archives of Medical Research (2 papers)Metabolism (1 paper)Frontiers in Oncology (1 paper)Cellular Oncology (1 paper)
- Partner nations
- MexicoCanadaUnited States
In The Last Decade
Alejandro Schcolnik‐Cabrera
34 papers receiving 822 citations
Peers
Comparison fields: 5 of 100
- Cancer Research 156
- Parasitology 55
- Infectious Diseases 122
- Small Animals 42
- Immunology 105
Countries citing papers authored by Alejandro Schcolnik‐Cabrera
This map shows the geographic impact of Alejandro Schcolnik‐Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Schcolnik‐Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Schcolnik‐Cabrera more than expected).
Fields of papers citing papers by Alejandro Schcolnik‐Cabrera
This network shows the impact of papers produced by Alejandro Schcolnik‐Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Schcolnik‐Cabrera. The network helps show where Alejandro Schcolnik‐Cabrera may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Schcolnik‐Cabrera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. | 2018 | 149 |
| 2 | 2018 | 106 | |
| 3 | 2019 | 87 | |
| 4 | 2020 | 87 | |
| 5 | 2019 | 56 | |
| 6 | Understanding tumor anabolism and patient catabolism in cancer-associated cachexia. | 2017 | 47 |
| 7 | 2020 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2020 | 30 | |
| 10 | 2019 | 26 | |
| 11 | 2021 | 19 | |
| 12 | Comparison of DNA demethylating and histone deacetylase inhibitors hydralazine-valproate versus vorinostat-decitabine incutaneous t-cell lymphoma in HUT78 cells. | 2018 | 17 |
| 13 | 2022 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2020 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2022 | 13 | |
| 18 | 2024 | 12 | |
| 19 | 2020 | 12 | |
| 20 | 2019 | 10 |
About Alejandro Schcolnik‐Cabrera
Alejandro Schcolnik‐Cabrera is a scholar working on Molecular Biology, Immunology, Cancer Research, Epidemiology and Infectious Diseases, having authored 35 papers that have together received 841 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Cancer, Lipids, and Metabolism (5 papers), Mycobacterium research and diagnosis (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Immune Cell Function and Interaction (3 papers), Immune cells in cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Cancer Research (156 citations), Parasitology (55 citations), Infectious Diseases (122 citations), Small Animals (42 citations) and Immunology (105 citations). Alejandro Schcolnik‐Cabrera has collaborated with scholars based in Mexico, Canada and United States. Frequent co-authors include Alfonso Dueñas‐González, Mandy Juárez, Guadalupe Domínguez-Gómez, Alma Chávez‐Blanco, Fela Mendlovic, Bernardo Oldak, Ana Flisser, Mayra Cruz‐Rivera, Aurora González‐Fierro and Lucía Taja‐Chayeb. Their work appears in journals such as Current Medicinal Chemistry, Archives of Medical Research, Metabolism, Frontiers in Oncology and Cellular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.